Allspring Global Investments
GMAB icon

Allspring Global Investments’s Genmab GMAB Stock Holding History

Allspring Global Investments’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$247K Buy
9,117
+1,986
+28% +$59.5K ﹤0.01% 1569
2025
Q4 		$226K Buy
7,131
+538
+8% +$16.8K ﹤0.01% 1564
2025
Q3 		$210K Buy
+6,593
New +$161K ﹤0.01% 1544
2024
Q4 		– Sell
-4,653
Closed -$113K – 2020
2024
Q3 		$113K Buy
4,653
+1,413
+44% +$37.8K ﹤0.01% 1767
2024
Q2 		$81.4K Buy
3,240
+1,787
+123% +$50.7K ﹤0.01% 1889
2024
Q1 		$43.5K Buy
+1,453
New +$42.7K ﹤0.01% 1973

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Allspring Global Investments's GMAB Position: Q1 2026 in Review

Allspring Global Investments increased its Genmab (GMAB) stake by 28% in Q1 2026, buying an estimated $59.5K and bringing the position to 9,117 shares worth $247K. The position accounts for ﹤0.01% of the portfolio, ranked #1569.

Allspring Global Investments first reported a position in GMAB in Q1 2024 and has held it in 6 quarters since. 274 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

  • Allspring Global Investments held 9,117 shares of Genmab worth $247K as of Q1 2026.
  • Allspring Global Investments bought 1,986 Genmab shares in Q1 2026, an estimated $59.5K.
  • Genmab made up ﹤0.01% of Allspring Global Investments's portfolio in Q1 2026, its #1569 holding.
  • Allspring Global Investments first reported a position in Genmab in Q1 2024 and has held it in 6 quarters since.
  • 274 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on Allspring Global Investments's 13F filing for Q1 2026, filed 5 May 2026.